Stock listing

Vyome Holdings, Inc.

Selected listing: H1O · GETTEX · EUR · DE

Vyome Holdings, Inc. (gettex:H1O), Health Technology. Latest release Oct 5, 2026: Vyome Receives USPTO Notice of Allowance for U.S. Patent Covering VT-1908…

H1O:GETTEXEURDEUpdated October 3, 2026

Ticker: gettex:H1O
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: gettex
Currency: EUR

Latest news from Vyome Holdings, Inc.

Vyome Receives USPTO Notice of Allowance for U.S. Patent Covering VT-1908, its Novel Topical Mycophenolate Program Targeting the $20+ Billion Ocular Inflammation Market

October 5, 2026

Vyome Appoints Experienced Public Company Finance Executive Jerry Leonard as Chief Financial Officer

September 14, 2026

Vyome Holdings Reports Second Quarter 2026 Results Highlighted by Advancement of Lead VT-1953 Program, Pipeline Expansion and Strong Balance Sheet

August 25, 2026

Vyome Granted Chinese Patent Strengthening Immuno-Inflammation Portfolio

July 1, 2026

Vyome Holdings Reports First Quarter 2026 Results With Key FDA Filings and Strong Balance Sheet

May 27, 2026

All Vyome Holdings, Inc. news →

Events

Replays

ReShape Lifesciences, Inc. (RSLS) Q2 2024 Earnings Call
Thu, Aug 15, 2024 · 04:30 PM ET
Watch
ReShape Lifesciences, Inc. (RSLS) Q1 2024 Earnings Call
Wed, May 15, 2024 · 04:30 PM ET
Watch
ReShape Lifesciences, Inc. (RSLS) Q4 2023 Earnings Call
Mon, Apr 01, 2024 · 04:30 PM ET
Watch